SCHEDULE: Nutex Health Stakeholder Files Schedule 13G Amendment

Pertento Partners LLP, Pertento Advisors LLC, Pertento Master Fund Limited, and Eduardo Marques have filed an amendment to Schedule 13G, reporting beneficial ownership of Nutex Health, Inc. common stock.

Summary

• This filing is an amendment to Schedule 13G, indicating a change in beneficial ownership of Nutex Health, Inc. common stock.
• The reporting persons include Pertento Partners LLP, Pertento Advisors LLC, Pertento Master Fund Limited, and Eduardo Marques.
• The filing date for this amendment is May 7, 2026, with the event date requiring the filing being May 1, 2026.
• Pertento Partners LLP, Pertento Advisors LLC, and Eduardo Marques each report beneficial ownership of 405,029 shares, representing 5.9% of the class.
• Pertento Master Fund Limited reports beneficial ownership of 361,201 shares, representing 5.3% of the class.
• All securities reported are directly owned by advisory clients of Pertento Partners LLP, with no single client (other than Pertento Master Fund Limited) deemed to beneficially own more than 5%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance information.

Positives

• The filing provides transparency regarding significant beneficial ownership of Nutex Health, Inc. stock.
• The reporting entities are clearly identified, along with their respective shareholdings and percentages.

Negatives

• The filing does not contain financial performance data or operational updates for Nutex Health, Inc.

Risks

• Potential for increased influence or control over Nutex Health, Inc. by the reporting persons, although the filing certifies no intent to influence control.
• Concentration of ownership among a few entities could lead to coordinated actions impacting the company's stock.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors and significant shareholders crossing certain ownership thresholds, providing transparency into ownership structures within the healthcare sector.

Stakeholder Impact

• Shareholders: Increased awareness of significant ownership stakes, potentially influencing market perception and trading activity.
• Management: May need to engage with or consider the interests of these significant beneficial owners.
• Creditors: No direct impact indicated, as the filing does not concern financial distress or restructuring.

Next Steps

• Continued monitoring of future Schedule 13G filings for any changes in beneficial ownership by these reporting persons.

Key Dates

Keywords

Schedule 13G, Nutex Health, Beneficial Ownership, Amendment, Pertento Partners, Pertento Advisors, Pertento Master Fund, Eduardo Marques, Common Stock, SEC Filing